Yazdani et al. identify gene signatures by integrating transcriptomic-causal networks into overall survival analysis, providing interpretable biomarkers for patient stratification. Gene signatures are found in metastatic colorectal cancer that indicate patients with specific profiles might benefit from cetuximab or bevacizumab.
- Akram Yazdani
- Heinz-Josef Lenz
- Federico Innocenti
